Try our Advanced Search for more refined results

November 04, 2019

AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. November 10, 2022

    Viatris Sways Judge To Ax AstraZeneca Inhaler Patent

    A West Virginia federal judge has granted drugmaker Viatris' bid to invalidate one of rival AstraZeneca's patents on brand name asthma treatment Symbicort, determining that the challenged claims are invalid for lack of enablement and lack of written description.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login